Get started
Author

Ushma D. Wadia

Immunogenicity of a Monovalent 2009 Influenza A(H1N1) Vaccine in Infants and Children
2009 · Terry Nolan, Jodie McVernon, et al. · JAMA · 192
Nirsevimab binding-site conservation in respiratory syncytial virus fusion glycoprotein worldwide between 1956 and 2021: an analysis of observational study sequencing data
2023 · Deidre Wilkins, Annefleur C Langedijk, et al. · The Lancet Infectious Diseases · 113
Effectiveness of nirsevimab in preventing RSV-hospitalisation among young children in Western Australia 2024
2025 · Ushma Wadia, Hannah C. Moore, et al. · Journal of Infection · 43
PDF
The genomic evolutionary dynamics and global circulation patterns of respiratory syncytial virus
2024 · Annefleur C. Langedijk, Bram Vrancken, et al. · Nature Communications · 38
PDF
International Pediatric COVID-19 Severity Over the Course of the Pandemic
2023 · Yanshan Zhu, Flávia Jacqueline Almeida, et al. · Archives of Pediatrics and Adolescent Medicine · 37
Immunogenicity and clinical effectiveness of the trivalent inactivated influenza vaccine in immunocompromised children undergoing treatment for cancer
2015 · Rishi S. Kotecha, Ushma D. Wadia, et al. · Cancer Medicine · 24
PDF
Revaccination with Bacille Calmette-Guérin (BCG) is associated with an increased risk of abscess and lymphadenopathy
2022 · Paola Villanueva, Ushma Wadia, et al. · npj Vaccines · 22
PDF
Nirsevimab immunisation of infants and respiratory syncytial virus ( RSV )‐associated hospitalisations, Western Australia, 2024: a population‐based analysis
2025 · Lauren E Bloomfield, Nevada V Pingault, et al. · The Medical Journal of Australia · 20
PDF
Immunogenicity of the inactivated influenza vaccine in children who have undergone allogeneic haematopoietic stem cell transplant
2019 · Anne L. Ryan, Ushma D. Wadia, et al. · Bone Marrow Transplantation · 20
PDF
BCG vaccination of healthcare workers for protection against COVID-19: 12-month outcomes from an international randomised controlled trial
2024 · Nicole L. Messina, Laure F. Pittet, et al. · Journal of Infection · 15
PDF
Characterization of Gram-negative Bloodstream Infections in Hospitalized Australian Children and Their Clinical Outcomes
2024 · Sophie C H Wen, Patrick N A Harris, et al. · Clinical Infectious Diseases · 15
Respiratory Syncytial Virus Reinfections in Children in Western Australia
2023 · David A. Foley, Cara A. Minney-Smith, et al. · Viruses · 15
PDF
The seroprevalence of SARS‐CoV ‐2‐specific antibodies in children, Australia, November 2020 – March 2021
2022 · Archana Koirala, Heather F Gidding, et al. · The Medical Journal of Australia · 15
Randomised Controlled Trial Comparing Daily Versus Depot Vitamin D3 Therapy in 0–16-Year-Old Newly Settled Refugees in Western Australia Over a Period of 40 Weeks
2018 · Ushma Wadia, Wayne Soon, et al. · Nutrients · 14
PDF
Specific and off-target immune responses following COVID-19 vaccination with ChAdOx1-S and BNT162b2 vaccines—an exploratory sub-study of the BRACE trial
2024 · Nicole L. Messina, Susie Germano, et al. · EBioMedicine · 12
Safety of BCG vaccination and revaccination in healthcare workers
2023 · Paola Villanueva, Nigel W. Crawford, et al. · Human Vaccines & Immunotherapeutics · 12
PDF
Respiratory Syncytial Virus Strain Evolution and Mutations in Western Australia in the Context of Nirsevimab Prophylaxis
2025 · Binit Lamichhane, Cara A Minney-Smith, et al. · Open Forum Infectious Diseases · 11
PDF
Bacille Calmette-Guérin vaccination to prevent febrile and respiratory illness in adults (BRACE): secondary outcomes of a randomised controlled phase 3 trial
2024 · Laure F. Pittet, Nicole L. Messina, et al. · EClinicalMedicine · 9
Bacillus Calmette-Guérin vaccination for protection against recurrent herpes labialis: a nested randomised controlled trial
2023 · Laure F. Pittet, Cecilia L. Moore, et al. · EClinicalMedicine · 8
PDF
Core protocol for the adaptive Platform Trial In COVID-19 Vaccine priming and BOOsting (PICOBOO)
2023 · C. McLeod, J Ramsay, et al. · Trials · 8
PDF
Revaccination outcomes of children with vaccine proximate seizures
2021 · Lucy Deng, Margie Danchin, et al. · Vaccine · 8
Factors influencing scar formation following Bacille Calmette-Guérin (BCG) vaccination
2023 · Paola Villanueva, Nigel W. Crawford, et al. · Heliyon · 7
PDF
Respiratory syncytial virus epidemiology and effectiveness of infant nirsevimab: 2024 results from the Australian Sentinel Hospital Network (FluCAN-PAEDS)
2026 · Christopher C Blyth, Ushma Wadia, et al. · Eurosurveillance · 6
PDF
The Platform Trial In COVID-19 Priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity, and safety of different COVID-19 vaccinations administered as a second booster (fourth dose) in AZD1222 primed individuals aged 50-<70 years old
2024 · C. McLeod, M. Dymock, et al. · Journal of Infection · 6
Australian hospital paediatricians and nurses’ perspectives and practices for influenza vaccine delivery in children with medical comorbidities
2022 · Daniel A. Norman, Margie Danchin, et al. · PLoS ONE · 6
PDF
Works count: 62
Citation count: 716
H-index: 14
I10-index: 17
Year
Topic
Type